Evidence map›Paper›PMID 26513745›Full record

ArticlePloS one2015

Comparison of NK-1 Receptor Antagonist (Maropitant) to Morphine as a Pre-Anaesthetic Agent for Canine Ovariohysterectomy.

Megan Marquez, Pedro Boscan, Heather Weir, Pamela Vogel, David C Twedt

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Perioperative Pain Management for Mastectomy in Dogs: A Narrative Review.Animals : an open access journal from MDPI · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Retrospective evaluation of maropitant and perioperative factors affecting postoperative appetite in cats.The Canadian veterinary journal = La revue veterinaire canadienne · 2021
    Article
  8. Article
  9. Update on Canine Parvoviral Enteritis.The Veterinary clinics of North America. Small animal practice · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Spotlight on the perioperative use of maropitant citrate.Veterinary medicine (Auckland, N.Z.) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Megan MarquezDepartment of Clinical Sciences, Veterinary Teaching Hospital, Colorado State University, Fort Collins, Colorado, United States of America.
Pedro BoscanDepartment of Clinical Sciences, Veterinary Teaching Hospital, Colorado State University, Fort Collins, Colorado, United States of America.
Heather WeirDepartment of Clinical Sciences, Veterinary Teaching Hospital, Colorado State University, Fort Collins, Colorado, United States of America.
Pamela VogelDepartment of Clinical Sciences, Veterinary Teaching Hospital, Colorado State University, Fort Collins, Colorado, United States of America.
David C TwedtDepartment of Clinical Sciences, Veterinary Teaching Hospital, Colorado State University, Fort Collins, Colorado, United States of America.
Colorado State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the NK-1 receptor antagonist maropitant to morphine during and after surgery in dogs undergoing ovariohysterectomy (OHE).

methods30 healthy female dogs were randomly divided to receive either a pre-anaesthetic dose of morphine (0.5 mg/kg SQ) or maropitant (1 mg/kg, SQ) prior to OHE. Anaesthesia was induced with propofol and maintained with isoflurane. Expired isoflurane concentration, heart rate (HR), systolic arterial pressure (SAP) and respiratory rate were measured. Post-operative pain scores and appetite were evaluated during the recovery period. Rescue analgesia (morphine 0.1 mg/kg IV) was administered as needed post-operatively based on blinded pain score assessments.

resultsAlthough clinically comparable; during surgical stimulation, the maropitant group had lower HR (108±18 vs 115±24 bpm; p = 0.04), lower SAP (114±23 vs 125±23 mmHg; p = 0.003) and required slightly lower percent of isoflurane anaesthetic (1.35±0.2 vs 1.51±0.4%; p = 0.005), when compared to the morphine group. In the recovery period, the maropitant group had lower pain scores at extubation (1.7±0.7 vs 3.4±2.3; p = 0.0001) and were more likely to eat within 3 hours after extubation (64.7 vs 15.3%). However, post-operative rescue analgesia requirements were similar between groups. All other measured parameters were similar between groups. The overall difference observed between groups was small and all monitored and measured parameters were within the expected range for anesthetized dogs. CLINICAL SIGNIFICANCE: No major differences in cardiorespiratory parameters or anaesthetic requirements were observed between maropitant and morphine when used as a pre-anesthetic agent for OHE. Further studies are necessary to fully elucidate the benefits of maropitant as a pre-anaesthetic agent for canine OHE.

Indexed as

Pain ManagementAnalgesicsAnimalsDogsFemaleMorphineOvariectomyPain MeasurementPostoperative PainPremedicationQuinuclidinesReceptors, Neurokinin-1AnalgesicsmaropitantMorphineQuinuclidinesReceptors, Neurokinin-1

Identifiers

PMID26513745
PMCPMC4626099
OpenAlexW1949918581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.